Please check your internet connection and try again.
## Sompraz HP
### Overview
Sompraz HP is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. Pantoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
### Primary Indications
Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
### Adult Dosing
* **Standard Regimen:** One pantoprazole 40 mg delayed-release tablet, two amoxicillin 500 mg capsules, and one clarithromycin 250 mg tablet or capsule administered orally twice daily for 7 days.
* **Note:** The specific formulation of Sompraz HP may contain different strengths of each component. Always verify the exact strengths of the provided product before dispensing. Dosing may vary based on local resistance patterns and established treatment guidelines.
### Pediatric Dosing
Pediatric dosing is not established for Sompraz HP.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is recommended for pantoprazole in mild to moderate renal impairment. Use with caution in severe renal impairment. Amoxicillin and clarithromycin may require dose adjustment in severe renal impairment; refer to individual drug monographs.
* **Hepatic Impairment:** No dose adjustment is recommended for pantoprazole in mild to moderate hepatic impairment. Use with caution in severe hepatic impairment. Clarithromycin may require dose adjustment in severe hepatic impairment.
### Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins, cephalosporins, or macrolides.
* Severe hepatic impairment (pantoprazole).
* Concomitant use with ergotamine or dihydroergotamine (clarithromycin).
* History of QT prolongation or ventricular arrhythmias (clarithromycin).
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) which increase the risk of arrhythmias (clarithromycin).
### Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, rash, dysgeusia (altered taste), vomiting, insomnia.
* **Serious:** *Clostridioides difficile*-associated diarrhea, anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatotoxicity, QT prolongation, *Clostridium difficile* colitis, tendon rupture (fluoroquinolones, though not in this product, but important to consider in antibiotic resistance patterns).
### Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs that require acidic environments (e.g., ketoconazole, itraconazole, iron salts). May interact with warfarin (monitor INR).
* **Amoxicillin:** May decrease the effectiveness of oral contraceptives. Probenecid may increase serum concentrations.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Interacts with a vast number of drugs, including statins (risk of myopathy), colchicine (risk of toxicity), certain anticoagulants (e.g., warfarin, apixaban, rivaroxaban - monitor INR/bleeding), calcium channel blockers, benzodiazepines, and digoxin. Avoid concomitant use with ergot derivatives.
### Monitoring
* Signs and symptoms of *H. pylori* infection recurrence.
* Signs of hypersensitivity reactions.
* Bowel function for *C. difficile* associated diarrhea.
* Liver function tests, especially with prolonged use or in patients with hepatic impairment.
* INR for patients on warfarin.
* Electrolytes if risk factors for prolonged QT interval are present.
### Clinical Pearls
* Administer medications consistently at the specified times to maintain therapeutic drug levels.
* Educate patients on completing the full course of therapy, even if symptoms improve.
* Advise patients to report any severe diarrhea, rash, or signs of allergic reaction immediately.
* Consider potential for antibiotic resistance when selecting therapy.
* Ensure adequate hydration, especially if diarrhea occurs.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.
